Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective
about
Risk and resistance perspectives in translation-oriented etiology researchAppropriate and inappropriate methods for investigating the "gateway" hypothesis, with a review of the evidence linking prior snus use to later cigarette smokingShattuck Lecture. A molecular basis for nicotine as a gateway drugBirth Cohorts Analysis of Adolescent Cigarette Smoking and Subsequent Marijuana and Cocaine UseA Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized TrialAssociation of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry CohortsThe Power of Theory, Research Design, and Transdisciplinary Integration in Moving Psychopathology Forward.Mechanisms and genetic factors underlying co-use of nicotine and alcohol or other drugs of abuse.Prior exposure to THC increases the addictive effects of nicotine in rats.Familiality of addiction and its developmental mechanisms in girls.Probability and predictors of the cannabis gateway effect: a national studyPredictors of onset of cannabis and other drug use in male young adults: results from a longitudinal study.A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework.Comorbidity and temporal relations of alcohol and cannabis use disorders from youth through adulthood.Associations between initial water pipe tobacco smoking and snus use and subsequent cigarette smoking: results from a longitudinal study of US adolescents and young adultsOverlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.Past-year gambling behaviour among patients receiving opioid substitution treatmentGenetic relationship between the addiction diagnosis in adults and their childhood measure of addiction liabilityParental transmission of risk for cannabis use disorders to offspring.Demographic and psychological factors associated with lifetime cocaine use: An exploratory factor analysis of baseline questionnaires.Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.Does the "gateway" sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy.Internalizing and externalizing psychopathology as predictors of cannabis use disorder onset during adolescence and early adulthood.Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United StatesTrends in Multiple Tobacco Product Use, Among High School StudentsIs the Use of Nutritional Supplements in Dosage Forms a "Gateway" to Oral Substance Abuse?Age of alcohol and cannabis use onset mediates the association of transmissible risk in childhood and development of alcohol and cannabis disorders: evidence for common liability.Cumulative contextual risk at birth in relation to adolescent substance use, conduct problems, and risky sex: General and specific predictive associations in a Finnish birth cohort.A qualitative study of methamphetamine initiation in Cape Town, South Africa.Risky Business: Pathways to Progress in Biologically Informed Studies of Psychopathology.Age of Sexual Debut and Cannabis Use in the United StatesIs Adolescent Poly-tobacco Use Associated with Alcohol and Other Drug Use?Misperception and accurate perception of close friend substance use in early adolescence: Developmental and intervention implicationsInternalizing and externalizing disorders as predictors of alcohol use disorder onset during three developmental periodsSusceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestryLongitudinal modeling of transmissible risk in boys who subsequently develop cannabis use disorderFitness supplements as a gateway substance for anabolic-androgenic steroid use.Illicit use of methadone and buprenorphine among adolescents and young adults in SwedenThe Gateway Hypothesis of substance abuse: developmental, biological and societal perspectives.Gateway effects and electronic cigarettes.
P2860
Q26751398-E91DB09B-6B22-4256-8F33-82B0D16BD2CFQ27014145-1DE75A24-FAB3-4324-A3DD-78F8F8258C76Q28247228-5711272C-334C-4D85-943E-C5FA212E6BC7Q28274853-5FBC908A-BD5A-41D1-BBED-4A2A0D76F744Q28550547-0E5857E6-946C-4601-B6A3-FDD1B65EC631Q30316113-D6CCECE0-E552-4613-811F-698ED72AC2D3Q30387529-4F823872-DA5B-4036-A35E-CA3B3AAFF730Q33859960-9E4747BB-FA26-46D6-803D-49F149DD0E86Q34322263-6A97B698-23E2-467F-9693-70883118FDCAQ34349579-71E1DB36-679D-48FF-A39F-EF69410154AFQ34435738-59039577-3757-407C-AA45-22422B8D3955Q34587419-3CAF50C7-D381-47FD-81F9-3643E9EE6F83Q34714161-834AFF2C-CC48-40A5-9474-27AB443CC903Q35181256-9547F55C-BBE3-4983-80EC-B43A5FB29F89Q35297979-FF425E2E-4C8F-49CE-9A74-5C372B0F7C80Q35439069-4ADD4354-46ED-429C-952C-51C47310F504Q35562706-07912EF8-67B6-4F3E-8244-A2D373FE3031Q35653685-5D90B230-6FF2-4E89-8377-AF1D99C9F540Q35777172-E2D5B424-E252-4C0E-888C-4567AA21DE0DQ35838639-D8010AF6-7412-4606-9FAD-7818F77D0BBDQ36028493-90FC6A5C-7AAA-4F5C-9BFB-4C287DE9EEA2Q36069581-610C6479-B1B8-4664-9B49-DF875CE76899Q36086971-5E82C697-2A88-4D3D-B7E4-2929559FC0C2Q36116978-F938B353-0B21-4178-A55B-3CFE19490558Q36165538-DA5C6E03-0F6A-4037-990D-90D81B9FE8AFQ36529326-A3416A86-6900-4FB9-9F7D-FA6B3BF2E183Q36589256-6F42A1C0-84D8-4579-AE54-386D7E6333E3Q36787056-FC2B4291-A91E-408E-8F5B-467854680E42Q36792076-58042D07-3028-468E-ABA9-71EE0BAD64B0Q36827127-9166D339-3E0F-4005-9265-453DBCAA3CB1Q36856616-D5178921-5598-4F46-8B12-EDC09D3CB686Q36908645-B908D531-3890-4B52-983F-A134B5CC58BCQ36935982-B51F22E6-F5D9-4B0D-99B0-3AF07D8F4E51Q36971578-8DA8F552-4811-4527-A6EC-D3CE68F65438Q36976562-3CCAE377-F26B-493E-AAC3-A5033AE23315Q37119485-BD08C165-D569-4756-BA61-4B5CCA22D5F5Q37338491-96EBA362-C5FA-4C30-A580-4C979C8333C3Q37369585-5EE29DFE-02B7-4E74-A218-F6C737000467Q38265948-2AC8FC51-C4D5-4891-9946-790F33974B60Q38635404-91A46C26-1D98-4CD3-AD27-7C7EC1A42AB3
P2860
Common liability to addiction and "gateway hypothesis": theoretical, empirical and evolutionary perspective
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Common liability to addiction ...... l and evolutionary perspective
@ast
Common liability to addiction ...... l and evolutionary perspective
@en
Common liability to addiction ...... l and evolutionary perspective
@nl
type
label
Common liability to addiction ...... l and evolutionary perspective
@ast
Common liability to addiction ...... l and evolutionary perspective
@en
Common liability to addiction ...... l and evolutionary perspective
@nl
prefLabel
Common liability to addiction ...... l and evolutionary perspective
@ast
Common liability to addiction ...... l and evolutionary perspective
@en
Common liability to addiction ...... l and evolutionary perspective
@nl
P2093
P2860
P50
P3181
P1476
Common liability to addiction ...... l and evolutionary perspective
@en
P2093
Brion S Maher
Duncan B Clark
Galina P Kirillova
Kevin P Conway
Levent Kirisci
Maureen D Reynolds
Michael M Vanyukov
Ralph E Tarter
Ty A Ridenour
William G Iacono
P2860
P3181
P356
10.1016/J.DRUGALCDEP.2011.12.018
P407
P478
123 Suppl 1
P577
2012-06-01T00:00:00Z